Arrieta, OscarBarrón, FelicianoSalinas Padilla, Miguel-ÁngelAvilés-Salas, AlejandroRamírez Tirado, Laura AlejandraArguelles Jiménez, Manuel JesúsVergara, EdgarZatarain Barrón, Zyanya LuciaHernández-Pedro, NormaCardona-Mendoza, Andrés FelipeCruz-Rico, GracielaBarrios-Bernal, PedroYamamoto Ramos, MasaoRosell, Rafael2020-05-122020-05-1220192374-2437https://hdl.handle.net/20.500.12495/2656application/pdfengEffect of metformin plus tyrosine kinase inhibitors compared with tyrosine kinase inhibitors alone in patients with epidermal growth factor receptor-mutated lung adenocarcinoma: A phase 2 randomized clinical trialarticleAnticolesterolemiantesMetforminaMiastenia gravishttps://doi.org/10.1001/jamaoncol.2019.2553Effect of metformin plus tyrosine kinase inhibitors compared with tyrosine kinase inhibitors alone in patients with epidermal growth factor receptor-mutated lung adenocarcinoma: A phase 2 randomized clinical trialAcceso cerrado2019